Healwell AI Inc. (TSX:AIDX)
Canada
· Delayed Price · Currency is CAD 1.510
-0.060 (-3.82%)
Mar 28, 2025, 4:00 PM EST
Healwell AI Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Revenue | 38.97 | 7.32 | 10.42 | 47.82 | 38.57 | Upgrade
|
| Revenue Growth (YoY) | 432.62% | -29.81% | -78.20% | 23.96% | -16.67% | Upgrade
|
| Cost of Revenue | 21.66 | 6.06 | 6.71 | 32.81 | 25.65 | Upgrade
|
| Gross Profit | 17.32 | 1.26 | 3.71 | 15.01 | 12.92 | Upgrade
|
| Selling, General & Admin | 45.08 | 14.04 | 13.78 | 33 | 16.86 | Upgrade
|
| Research & Development | 5.8 | 4.81 | 8.14 | 0.16 | - | Upgrade
|
| Operating Expenses | 50.87 | 18.85 | 21.92 | 33.15 | 16.86 | Upgrade
|
| Operating Income | -33.56 | -17.59 | -18.21 | -18.14 | -3.93 | Upgrade
|
| Interest Expense | -1.97 | -1.58 | -0.62 | -0.46 | -0.5 | Upgrade
|
| Interest & Investment Income | - | 0.24 | 0.02 | 0.11 | 0.06 | Upgrade
|
| Earnings From Equity Investments | - | - | -0.21 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.95 | -0.42 | -0.04 | -0.1 | -0.09 | Upgrade
|
| EBT Excluding Unusual Items | -36.48 | -19.35 | -19.06 | -18.6 | -4.46 | Upgrade
|
| Impairment of Goodwill | - | -5.35 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.28 | -2.31 | -0.4 | - | - | Upgrade
|
| Asset Writedown | -5.61 | -5.54 | - | - | - | Upgrade
|
| Other Unusual Items | 13.53 | -0.9 | 1.64 | 1.64 | 2.97 | Upgrade
|
| Pretax Income | -28.28 | -32.68 | -17.08 | -16.29 | -1.34 | Upgrade
|
| Income Tax Expense | -1.69 | -0.54 | 1.12 | -0.75 | -0.31 | Upgrade
|
| Earnings From Continuing Operations | -26.6 | -32.14 | -18.2 | -15.54 | -1.03 | Upgrade
|
| Earnings From Discontinued Operations | -0.05 | 0.6 | -2.78 | - | - | Upgrade
|
| Net Income to Company | -26.65 | -31.55 | -20.97 | -15.54 | -1.03 | Upgrade
|
| Minority Interest in Earnings | 1.19 | -0.05 | -0.12 | -0.13 | -0 | Upgrade
|
| Net Income | -25.46 | -31.6 | -21.09 | -15.67 | -1.03 | Upgrade
|
| Net Income to Common | -25.46 | -31.6 | -21.09 | -15.67 | -1.03 | Upgrade
|
| Shares Outstanding (Basic) | 136 | 57 | 50 | 48 | 38 | Upgrade
|
| Shares Outstanding (Diluted) | 136 | 57 | 50 | 48 | 38 | Upgrade
|
| Shares Change (YoY) | 137.69% | 13.89% | 4.33% | 25.22% | 0.86% | Upgrade
|
| EPS (Basic) | -0.19 | -0.55 | -0.42 | -0.33 | -0.03 | Upgrade
|
| EPS (Diluted) | -0.19 | -0.55 | -0.42 | -0.33 | -0.03 | Upgrade
|
| Free Cash Flow | -25.14 | -10.86 | -8.64 | -7.93 | 4.14 | Upgrade
|
| Free Cash Flow Per Share | -0.18 | -0.19 | -0.17 | -0.17 | 0.11 | Upgrade
|
| Gross Margin | 44.43% | 17.18% | 35.59% | 31.39% | 33.51% | Upgrade
|
| Operating Margin | -86.10% | -240.43% | -174.68% | -37.94% | -10.19% | Upgrade
|
| Profit Margin | -65.34% | -431.83% | -202.27% | -32.77% | -2.67% | Upgrade
|
| Free Cash Flow Margin | -64.50% | -148.48% | -82.87% | -16.59% | 10.72% | Upgrade
|
| EBITDA | -26.26 | -16.11 | -16.73 | -17.05 | -3.46 | Upgrade
|
| EBITDA Margin | -67.38% | -220.21% | -160.45% | -35.66% | -8.97% | Upgrade
|
| D&A For EBITDA | 7.3 | 1.48 | 1.48 | 1.09 | 0.47 | Upgrade
|
| EBIT | -33.56 | -17.59 | -18.21 | -18.14 | -3.93 | Upgrade
|
| EBIT Margin | -86.10% | -240.43% | -174.68% | -37.94% | -10.19% | Upgrade
|
| Revenue as Reported | 38.97 | - | - | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.